Early Chemoprophylaxis Against Venous Thromboembolism in Patients With Traumatic Brain Injury.


Journal

The American surgeon
ISSN: 1555-9823
Titre abrégé: Am Surg
Pays: United States
ID NLM: 0370522

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 28 1 2021
medline: 14 1 2022
entrez: 27 1 2021
Statut: ppublish

Résumé

Timing to start of chemoprophylaxis for venous thromboembolism (VTE) in patients with traumatic brain injury (TBI) remains controversial. We hypothesize that early administration is not associated with increased intracranial hemorrhage. A retrospective study of adult patients with TBI following blunt injury was performed. Patients with penetrating brain injury, any moderate/severe organ injury other than the brain, need for craniotomy/craniectomy, death within 24 hours of admission, or progression of bleed on 6 hour follow-up head computed tomography scan were excluded. Patients were divided into early (≤24 hours) and late (>24 hours) cohorts based on time to initiation of chemoprophylaxis. Progression of bleed was the primary outcome. 264 patients were enrolled, 40% of whom were in the early cohort. The average time to VTE prophylaxis initiation was 17 hours and 47 hours in the early and late groups, respectively ( Early chemoprophylaxis is not associated with progression of hemorrhage or need for neurosurgical intervention in patients with TBI and a stable head CT 7 hours following injury.

Identifiants

pubmed: 33502231
doi: 10.1177/0003134820983171
doi:

Substances chimiques

Anticoagulants 0
Factor Xa Inhibitors 0
Heparin, Low-Molecular-Weight 0
Heparin 9005-49-6

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-193

Auteurs

Lisbi Rivas (L)

Center for Trauma and Critical Care, Department of Surgery, 50430George Washington University, Washington, DC, USA.

Michael Vella (M)

Department of Surgery, Division of Traumatology, Surgical Critical Care, and Emergency Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Department of Surgery at the University of Rochester Medical Center, Rochester, NY, USA.

Tammy Ju (T)

Center for Trauma and Critical Care, Department of Surgery, 50430George Washington University, Washington, DC, USA.

Joseph S Fernandez-Moure (JS)

Department of Surgery, Division of Traumatology, Surgical Critical Care, and Emergency Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Department of Surgery at Duke Medical Center, 14640University of Pennsylvania Perelman School of Medicine, Durham, NC, USA.

Andrew Sparks (A)

Center for Trauma and Critical Care, Department of Surgery, 50430George Washington University, Washington, DC, USA.

Mark J Seamon (MJ)

Department of Surgery, Division of Traumatology, Surgical Critical Care, and Emergency Surgery, University of Pennsylvania, Philadelphia, PA, USA.

Babak Sarani (B)

Center for Trauma and Critical Care, Department of Surgery, 50430George Washington University, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH